Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Hui Lai

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Clinical Epigenetics|January 29, 2015
Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patientsJian-Liang Chou, Rui-Lan Huang, Jacqueline Shay, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 13, 2010
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancerJian-Liang Chou, Her-Young Su, Lin-Yu Chen, et al.
Oncotarget|December 3, 2014
DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating studyHon-Yi Lin, Shih-Kai Hung, Moon-Sing Lee, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical Epigenetics|January 29, 2015
Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patientsJian-Liang Chou, Rui-Lan Huang, Jacqueline Shay, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 13, 2010
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancerJian-Liang Chou, Her-Young Su, Lin-Yu Chen, et al.
Oncotarget|December 3, 2014
DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating studyHon-Yi Lin, Shih-Kai Hung, Moon-Sing Lee, et al.
Pageof 3